These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 7570717

  • 21. Steroidal inhibitors as chemical probes of the active site of aromatase.
    Brueggemeir RW, Moh PP, Ebrahimian S, Darby MV.
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):357-65. PubMed ID: 8476749
    [Abstract] [Full Text] [Related]

  • 22. 6 beta-Propynyl-substituted steroids: mechanism-based enzyme-activated irreversible inhibitors of aromatase.
    Akkani A, Paterlini G, Gleason WB, Ojala WH, Abul-Hajj YJ.
    J Med Chem; 1997 Sep 26; 40(20):3263-70. PubMed ID: 9379446
    [Abstract] [Full Text] [Related]

  • 23. A photoaffinity inhibitor of aromatase.
    Brueggemeier RW, Snider CE, Kimball JG.
    Steroids; 1982 Dec 26; 40(6):679-89. PubMed ID: 7187716
    [Abstract] [Full Text] [Related]

  • 24. Enzyme inactivation by potential metabolites of an aromatase-activated inhibitor (MDL 18,962).
    Johnston JO, Wright CL, Holbert GW, Benson HD.
    J Enzyme Inhib; 1990 Dec 26; 4(2):137-42. PubMed ID: 2098520
    [Abstract] [Full Text] [Related]

  • 25. Probing the binding pocket of the active site of aromatase with 6-ether or 6-ester substituted androst-4-ene-3,17-diones and their diene and triene analogs.
    Numazawa M, Shelangouski M, Nagasaka M.
    Steroids; 2000 Dec 26; 65(12):871-82. PubMed ID: 11077085
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments.
    Klein H, Bartsch W, Niemand A, Stürenburg HJ, Voigt KD.
    J Steroid Biochem; 1988 Feb 26; 29(2):161-9. PubMed ID: 3347056
    [Abstract] [Full Text] [Related]

  • 27. Substrate specificity of the placental microsomal aromatase.
    Gibb W, Lavoie JC.
    Steroids; 1980 Nov 26; 36(5):507-19. PubMed ID: 7456098
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo.
    Brodie AM, Garrett WM, Hendrickson JR, Tsai-Morris CH, Marcotte PA, Robinson CH.
    Steroids; 1981 Dec 26; 38(6):693-702. PubMed ID: 7336466
    [Abstract] [Full Text] [Related]

  • 30. Enzymic aromatization of 6-alkyl-substituted androgens, potent competitive and mechanism-based inhibitors of aromatase.
    Numazawa M, Yoshimura A, Oshibe M.
    Biochem J; 1998 Jan 01; 329 ( Pt 1)(Pt 1):151-6. PubMed ID: 9405288
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Enzyme-generated intermediates derived from 4-androstene-3,6,17-trione and 1,4,6-androstatriene-3,17-dione cause a time-dependent decrease in human placental aromatase activity.
    Covey DF, Hood WF.
    Endocrinology; 1981 Apr 01; 108(4):1597-9. PubMed ID: 7472286
    [Abstract] [Full Text] [Related]

  • 35. 7alpha-Arylaliphatic androsta-1,4-diene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase.
    O'Reilly JM, Brueggemeier RW.
    J Steroid Biochem Mol Biol; 1996 Sep 01; 59(1):93-102. PubMed ID: 9009242
    [Abstract] [Full Text] [Related]

  • 36. Ovine placental aromatase: studies of activity levels, kinetic characteristics and effects of aromatase inhibitors.
    France JT, Mason JI, Magness RR, Murry BA, Rosenfeld CR.
    J Steroid Biochem; 1987 Aug 01; 28(2):155-60. PubMed ID: 3626552
    [Abstract] [Full Text] [Related]

  • 37. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
    Covey DF, Hood WF.
    Cancer Res; 1982 Aug 01; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195
    [Abstract] [Full Text] [Related]

  • 38. Synthesis and biochemical properties of 6-bromoandrostenedione derivatives with a 2,2-dimethyl or 2-methyl group as aromatase inhibitors.
    Numazawa M, Handa W, Yamada K.
    Biol Pharm Bull; 2004 Nov 01; 27(11):1878-82. PubMed ID: 15516742
    [Abstract] [Full Text] [Related]

  • 39. 19-oxygenated derivatives of androst-4-ene-6,17-dione and androst-5-ene-4,17-dione as catalytic probes for the active site of aromatase.
    Numazawa M, Yamada K, Kidokoro K.
    Biol Pharm Bull; 1999 Oct 01; 22(10):1134-6. PubMed ID: 10549872
    [Abstract] [Full Text] [Related]

  • 40. Biochemical and pharmacological development of steroidal inhibitors of aromatase.
    Brueggemeier RW, Li PK, Chen HH, Moh PP, Katlic NE.
    J Steroid Biochem Mol Biol; 1990 Nov 20; 37(3):379-85. PubMed ID: 2257241
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.